Telix Pharmaceuticals (ASX:TLX) will change its reporting currency to US dollars from Australian dollars, effective Jan. 1, according to a Tuesday Australian bourse filing.
The change allows the company to align to the predominant currency used for reporting revenue, costs, and corresponding cash flows, which are primarily generated in the US, the filing added.
The company will also convert the comparative periods in upcoming financial results to US dollars, per the filing.
The company's shares fell almost 1% in recent Tuesday trade but earlier hit an all-time high.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.